Farther Finance Advisors LLC Reduces Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Farther Finance Advisors LLC decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 34.9% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,943 shares of the company’s stock after selling 1,577 shares during the quarter. Farther Finance Advisors LLC’s holdings in GE HealthCare Technologies were worth $230,000 as of its most recent filing with the SEC.

Several other hedge funds also recently made changes to their positions in GEHC. OneDigital Investment Advisors LLC grew its holdings in shares of GE HealthCare Technologies by 7.5% during the third quarter. OneDigital Investment Advisors LLC now owns 13,798 shares of the company’s stock worth $1,295,000 after purchasing an additional 961 shares during the last quarter. Empowered Funds LLC grew its holdings in shares of GE HealthCare Technologies by 30.7% during the third quarter. Empowered Funds LLC now owns 23,470 shares of the company’s stock worth $2,203,000 after purchasing an additional 5,512 shares during the last quarter. Mutual of America Capital Management LLC grew its holdings in shares of GE HealthCare Technologies by 5.0% during the third quarter. Mutual of America Capital Management LLC now owns 56,349 shares of the company’s stock worth $5,288,000 after purchasing an additional 2,696 shares during the last quarter. Thrivent Financial for Lutherans grew its holdings in shares of GE HealthCare Technologies by 16.5% during the third quarter. Thrivent Financial for Lutherans now owns 25,408 shares of the company’s stock worth $2,385,000 after buying an additional 3,602 shares during the last quarter. Finally, Swiss National Bank grew its holdings in shares of GE HealthCare Technologies by 0.5% during the third quarter. Swiss National Bank now owns 1,287,187 shares of the company’s stock worth $120,802,000 after buying an additional 6,500 shares during the last quarter. Hedge funds and other institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Price Performance

GEHC stock opened at $82.14 on Wednesday. The firm has a 50 day moving average of $87.25 and a 200-day moving average of $86.10. GE HealthCare Technologies Inc. has a 12-month low of $74.51 and a 12-month high of $94.80. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88. The company has a market cap of $37.56 billion, a price-to-earnings ratio of 18.97, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Thursday, February 13th. The company reported $1.45 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. GE HealthCare Technologies had a net margin of 10.13% and a return on equity of 25.74%. The company had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. As a group, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently issued reports on GEHC. Jefferies Financial Group raised GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the stock from $95.00 to $103.00 in a report on Wednesday, January 8th. Wells Fargo & Company raised their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a report on Friday, February 14th. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and raised their price target for the stock from $85.00 to $100.00 in a report on Tuesday, March 11th. Finally, Citigroup raised their price target on GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a report on Thursday, February 13th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.